Insider Transactions

What Coya Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Goldstein Dov A Md	Director	Aug 18	Exercise / conversion · M	+17,557	$1.09	+$19.1K	27,557
Snyder David S	Chief Financial Officer	Nov 14	Open-market buy · P	+1,800	$7.19	+$12.9K	8,800
Swaminathan Arun	Chief Executive Officer	Nov 13	Open-market buy · P	+5,000	$7.36	+$36.8K	10,000
Grossman Fred	Chief Medical Officer	Nov 11	Open-market buy · P	+2,710	$7.37	+$20K	2,710
Swaminathan Arun	Chief Executive Officer	Nov 11	Open-market buy · P	+5,000	$7.34	+$36.7K	5,000
Lee Ann	Director	Aug 22	Open-market buy · P	+1,000	$3.62	+$3.62K	17,479
Lee Ann	Director	Jan 03	Derivative Conversion · C	+6,479	$4.00	+$25.9K	16,479
Lee Ann	Director	Jan 03	Open-market buy · P	+10,000	—	—	10,000
Villalobos Anabella	Director	Jan 03	Open-market buy · P	+10,000	—	—	10,000
Snyder David S	Chief Financial Officer	Jan 03	Open-market buy · P	+7,000	—	—	7,000
Hepner Adrian	Chief Medical Officer	Jan 03	Open-market buy · P	+10,000	—	—	10,000
Garren Hideki	Director	Jan 03	Open-market buy · P	+2,000	—	—	2,000
Goldstein Dov A Md	Director	Jan 03	Open-market buy · P	+10,000	—	—	10,000

Page 1 of 1 · showing the 13 most recent Sign up free to view all 13 transactions and filter by insider →